WO2010098595A2 - Composition for skin external applicationcontaining red pine root extract - Google Patents
Composition for skin external applicationcontaining red pine root extract Download PDFInfo
- Publication number
- WO2010098595A2 WO2010098595A2 PCT/KR2010/001180 KR2010001180W WO2010098595A2 WO 2010098595 A2 WO2010098595 A2 WO 2010098595A2 KR 2010001180 W KR2010001180 W KR 2010001180W WO 2010098595 A2 WO2010098595 A2 WO 2010098595A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- skin
- pine root
- expression
- root extract
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9755—Gymnosperms [Coniferophyta]
- A61K8/9767—Pinaceae [Pine family], e.g. pine or cedar
Definitions
- the present invention relates to a composition for skin external application containing a pine root extract. More specifically, the composition for skin external application according to the present invention contains, as an active ingredient, a pine root extract which shows various effects, including eliminating free radicals, protecting the cell membrane from damage by UV irradiation, inhibiting the production of reactive oxygen species caused by UV radiation, inhibiting the reduction in the expression of superoxide dismutase (SOD) and catalase caused by UV radiation, stimulating the production of HSP70 to protect cells, inhibiting MMP-2 biosynthesis caused by UV radiation, inducing the expression of SIRTl gene that restores DNA damage, and inducing the expression of LMNAl gene that maintains the structure of the nuclear membrane.
- the composition of the present invention prevents skin aging.
- Skin tissue contains various antioxidant systems and protective factors for protecting the skin, for example, a heat shock protein (HSP).
- HSP heat shock protein
- MMPs matrix metal loproteinases
- antioxidant substances capable of protecting skin cells substances capable of inhibiting the biosynthesis of MMPs that degrade the collagen of the skin, substances that prevent damage to skin cells, substances inducing the production of proteins for restoring intracellular DNA damage and proteins for maintaining the structure of the nuclear membrane, etc., relieve skin aging.
- Pine trees have been called “Song-jeol” in Korean for the stem and branch knobs, “Song-keun” in Korean for young roots or root cortex, “Song- phi 1-du” in Korean for young branches and branch tops, “Song-yeup” in Korean for leaves, “Song-hwa-bun” in Korean for pollen, “Song-goo” in Korean for round fruits, and “Song-mok-pi” in Korean for barks, and these pine tree portions have been used for medicinal purposes.
- the pine root is picked in the spring season and dried for use.
- the pint tree root is known to bitter in taste, warm in nature and non-toxic. Also, it contains medicinal components, including 75% ⁇ -pinene 75%, camphene, dipentene, ⁇ -terpinenol , camphor, and p-mentanol .
- a composition for skin external application according to the present invention contains a pine root extract. ⁇ 13> Also, the composition for skin external application according to the present invention is used to prevent skin aging. ⁇ 14> Also, the composition for skin external application according to the present invention is used to protect the cell membrane from damage caused by
- composition for skin external application according to the present invention is used to protect cells that promote the production of
- the composition for skin external application according to the present invention is used to inhibit the biosynthesis of MMP-2 caused by UV radiation.
- the composition for skin external application according to the present invention is used to induce the expression of SIRTl gene that restores DNA damage and the expression of LMNAl gene that maintains the structure of the nuclear membrane.
- the composition for skin external application according to the present invention is used to alleviate skin wrinkles.
- the composition for skin external application according to the present invention is used to promote skin regeneration.
- the composition for skin external application according to the present invention contains a pine root extract.
- the composition of the present invention has the effect of inhibiting photoaging caused by UV radiation and shows the effect of secreting regulatory substances resisting excessive intrinsic or extrinsic stresses in cells to prevent cell damage from occurring.
- the composition of the present invention is excellent in the effect of inhibiting MMP activity, which is an index of skin anti-aging.
- the composition of the present invention has excellent effects of inducing the expression of SIRTl gene that restores DNA damage and inducing the expression of LMNAl gene that maintains the structure of the nuclear membrane. Accordingly, the inventive composition for skin external application containing a pine root extract alleviates skin wrinkles to inhibit skin aging.
- FIG. 1 shows the effect of the inventive pine root (red pine root) extract on the expression of SOD and catalase.
- FIG. 2 shows the effect of the inventive pine root (red pine root) extract on the expression of HSP70 protein.
- FIG. 3 shows the effect of the inventive pine root (red pine root) extract on the expression of SIRTl gene and LMNAl gene.
- Red pine which is used in the present invention is pinus dens/flora Siebold et Zuccarini) belonging to the family Pinaceae, and is bitter in taste and warm in nature and no-toxic. It acts on the spleen meridian and the heart meridian and has been used long ago to treat a swelling caused by wind/dampness, Tinea cruris, leprosy, incised wound, etc.
- the pine root extract which is used in the present invention can be prepared by extracting the root of red pine in a solvent such as an aqueous ethanol solution according to a conventional method known in the art.
- a solvent such as an aqueous ethanol solution
- the sap of the pine root may be directly used without any treatment .
- composition for skin external application according to the present invention may contain the pine root extract in an amount of 0.001-99 wt% based on the total weight of the composition.
- the composition for skin external application according to the present invention contains a cosmetically and skin-scientifically acceptable medium and/or base.
- the composition may be formulated as a preparation for local application.
- formulations for local application include solution, gel, solid or dough anhydride, emulsion prepared by dispersing oil phase in water phase, suspension, microemulsion, microcapsule, microgranule, ionic (liposome) and/or non-ionic vesicle, cream, skin, lotion powder, spray, and conceal stick.
- the composition of the present invention can be formulated according to a conventional method known in the art.
- the composition for skin external application according to the present invention can be formulated as a foam composition or an aerosol composition further containing a compressed propel lant.
- composition for skin external application may contain additives which are conventionally field in the cosmetic field or the skin science field, for example, fatty substance, organic solvent, resolvent, thickener, gelling agent, softener, antioxidant, suspending agent, stabilizer, foaming agent, aromatic, surfactant, water, ionic or non-ionic emulsifying agent, filler, sequestering agent, chelating agent, preserving agent, vitamins, blocker, moisturizing agent, essential oil, dye, pigment, hydrophilic or hydrophobic activator, lipid vesicle or other components.
- additives are contained in amounts which are generally used in the cosmetic field or the skin science field.
- Example 1 Preparation of pine root (red pine root) extract ⁇ 36> 1 kg of pine roots were added to 5 liters of 80% ethanol aqueous solution, and extracted three times under reflux, and then dipped at 15 ° C for 1 day. Then, the extract was filtered through filter cloth and centrifuged to separate it into residue and the filtrate. The separated filtrate was concentrated under reduced pressure, thus obtaining 173 g of a pine root extract .
- Example 1 To measure antioxidant activity, the l,l-diphenyl-2-pycryl-hydrazyl (DPPH) method was used. Specifically, each of the extracts obtained in Example 1 and Comparative Example 1 was diluted in ethanol to varying concentrations (0, 50, 100, 200, 300 and 400 ⁇ g/nL) , and 10 ⁇ i of each dilution was added to each well of a 96-well plate. A solution of 5 mM DPPH in ethanol was added to each well to a total volume of 200 ⁇ i. The resulting solution was incubated at 37°C for 30 minutes, and then measured at 520 nm using an ELISA reader (DI Biotech, Korea). Based on the measured absorbance, free radical removal activity was calculated according to the following equation 1. As a positive control, vitamin C known to have excellent antioxidant activity was used. The test results are shown in Table 1 below.
- the pine root (red pine root) extract of Example 1 showed excellent radical removal activity compared to the red pine leaf extract of Comparative Example 1. As the concentration of the extract of Example 1 was increased, the extract of Example 1 showed radical removal activity comparable to that of vitamin C known as a powerful ant ioxidant .
- Test Example 2 Measurement of cell membrane against damage ⁇ 49> 100 ⁇ of a human keratinocyte HaCaT cell line obtained from the German Cancer Research Center (Heidelberg, Germany) was added to each well of a 96- well plate at a density of 1 x 10 cells/mL and cultured in a 5% CO2 incubator at 37°C . Then, cultures each containing each of the extracts of Example 1 and Comparative Example 1 at varying concentrations of 0.625, 1.25, 2.5 and 5 ⁇ g/mL were added to each well and cultured for 3 hours. After 3 hours, 50 ⁇ JLof the culture broth was removed, and phosphate buffered saline was added to each well.
- Each well was irradiated with 30 mJ/cnf of UV light using a UV- B lamp, followed by removal of the phosphate buffered saline. Then, 200 ⁇ i of each of the cell cultures containing the extract at the above concentrations was added to each well and cultured for 24 hours. After 24 hours of the culture, a suitable amount of the supernatant of each culture was taken, and the amount of lactate dehydrogenase (LDH), an index of cell damage, was measured using a cytotox 96 non-radioactive cytotoxicity assay kit. The measurement was repeated six times and averaged. The measurement results are shown in Table 2 below.
- a control group was a group treated with neither the extract of Example 1 nor the extract of Comparative Example 1.
- Example 1 37°C for 24 hours. Then, the cells were treated with each of the extracts of Example 1 and Comparative Example 1 at a concentration of 5 ⁇ g/mL and cultured for 24 hours. Then, each well was washed with phosphate buffered saline to remove the remaining culture medium and irradiated with UV B light. Then, the phosphate buffered saline was removed, and the cells were treated with each extract and cultured for 48 hours.
- the cells were collected and lysed with lysis buffer (containing 250 mM NaCl, 25 mM Tris-HCl pH 7.5, 5 mM EDTA pH 8.0, 1% NP-40, 0.1 M PMSF, 1 M DTT, protease inhibitor cocktail, and deionized water (DW)) at 4"C .
- lysis buffer containing 250 mM NaCl, 25 mM Tris-HCl pH 7.5, 5 mM EDTA pH 8.0, 1% NP-40, 0.1 M PMSF, 1 M DTT, protease inhibitor cocktail, and deionized water (DW)
- BCA reagent Equivalent amounts of proteins were mixed with a buffer containing each extract to prepare samples, which were then separated by electrophoresis on sodium dodesyl sulfate (SDS) polyacrylamide gel.
- SDS sodium dodesyl sulfate
- the acrylamide gel containing the separated proteins was transferred to a nitrocellulose membrane by electroblotting, and then washed twice with TBS-T (0.1% Tween 20 in TBS) containing 5% skim milk. After washing, the membrane was treated with each of anti-SOD and anti-catalase primary antibodies (1:2,000), incubated at 4 ° C for 12 hours, and then incubated with secondary antibodies corresponding to the primary antibodies (1:2,000) at room temperature for 1 hour. The membrane was washed with TBS-T, and then an ECL (enhanced chemi luminescence) solution was applied thereto.
- TBS-T 0.1% Tween 20 in TBS
- ECL enhanced chemi luminescence
- the membrane was sensitized to an X-ray film in a dark room, and the expression patterns of SOD and catalase were comparatively analyzed. In order to confirm whether equal amounts of the proteins were loaded, the above analysis procedure was repeated using actin as primary antibody. The analysis results are shown in FIG. 1.
- pine root extract according to the present invention shows an antioxidant effect by itself, and also has an excellent effect of protecting intracellular antioxidant enzyme systems against damage caused by endogenous or exogenous oxidative stress, indicating that the pine root extract has a function of protecting cells.
- HSP70 which is induced in response to stress protects cells individuals against various stresses and also prevents apoptosis. Also, it is known that the over-expressed HSP70 protein protects cells from stress or various toxicities.
- 2 ml of normal fibroblasts were added to each well of a 6-well plate at a density of 1 x 10 cells/mL and cultured in a 5% CO2 incubator at 37°C for 24 hours. Then, the cells were treated with 1 ⁇ g/mL of each of the extracts of Example 1 and Comparative Example 1, cultured for 24 hours and lysed with lysis buffer at 4 ° C.
- proteins were quantified with BCA reagent. Equivalent amounts of proteins were mixed with a buffer containing each extract to prepare samples, which were then separated by electrophoresis on sodium dodesyl sulfate polyacrylamide gel. For Western blot analysis, the acrylamide gel containing the separated proteins was transferred to a nitrocellulose membrane by electroblotting, and then stained with Ponceau S to conform that equal amounts of proteins have been transferred. The membrane to which the proteins were transferred was incubated in TBS-T (0.1% Tween 20 in TBS) containing 5% skim milk at room temperature for 1 hour to block nonspecific proteins and was washed twice with TBS-T.
- TBS-T 0.1% Tween 20 in TBS
- the membrane was treated with HSP70 primary antibody (1:1,000), incubated overnight at 4"C , and then incubated with secondary antibody (1:2,000) corresponding to the primary antibody at room temperature for 1 hour.
- the membrane was washed with TBS-T, and then an ECL (enhanced chemi luminescence) solution was applied thereto. Then, the membrane was sensitized to an X-ray film in a dark room, and the expression patterns of HSP70 protein were comparatively analyzed. The analysis results are shown in FIG. 2.
- each of the extracts of Examples 1 and Comparative Example 1 was added to the cells at varying concentrations of 0.25, 0.5 and 1 ⁇ g/mL. Then, the cells were irradiated with 30 mJ/cnf of UV B in the same manner as described in Example 5, and then treated with the pine root extract and cultured for 24 hours. Then, the cell culture was collected and mixed with a buffer containing the pine root extract to prepare samples, which were then loaded onto zymogram gel containing gelatin. Then, proteins on the zymogram gel were separated by electrophoresis.
- the zymogram gel containing the separated proteins was incubated at room temperature for 30 minutes in renaturing buffer (2.7% Triton X-100) according to the manufacturer s instruction and incubated in developing buffer [containing 50 mM Tris Base, 40 mM 6N HCl, 200 mM NaCl, 5 mM CaCl 2 • H 2 O, BriJ 350.02%] at room temperature overnight. Then, the gel was incubated in fresh developing buffer at 37 ° C overnight. The incubated gel was stained to determine the degree of biosynthesis of MMP-2.
- the cells were collected, lysed with lysis buffer at 4 °C , transferred to a nitrocellulose membrane by electroblotting, and then stained with Ponceau S to confirm that equal amounts of proteins were transferred.
- the test results are shown in Table 4 below.
- DMEM medium containing 10% (v/v) FBS, penicillin 100 U/ml and streptomycin 100 ⁇ g/ml
- the HaCaT cells prepared at a concentration
- 0.5 g/1 oligo (dT) 16 primer and 200 U Superscript II (GiboBRL) reverse transcriptase were added thereto and allowed to react at 42 ° C for 1 hour.
- FIG. 3 The test results are shown in FIG. 3. As can be seen in FIG. 3, when the cells were treated with 1 ⁇ g/mL of the pine root extract of Example 1, the expression of the SIRTl gene that restores DNA damage caused by aging and the expression of the LMNAl gene that maintains the nuclear membrane structure providing a barrier for DNA were induced, and the gene expression- inducing effect of the pine root extract of Example 1 was excellent compared to that of the red pine leaf extract. This suggests that the pine root extract of the present invention can induce the expression of the SIRTl and LMNAl genes, thus restoring DNA damage caused by aging and maintaining the nuclear membrane structure providing a barrier for DNA.
- cream of Formulation Examples 1 to 3 and Comparative Formulation Examples 1 and 2 were prepared by completely dissolving an oily phase and an aqueous phase at 70 ° C and emulsifying the solution at 7,000 rpm for 5 minutes (unit: wt%) .
- Test Example 8 Effect of reducing skin wrinkles ⁇ 81> The skin wrinkle-reducing effects of Formulation Examples 2 and 3 and Comparative Examples 1 and 2 were evaluated on human subjects. ⁇ 82> On 25 women subjects (30-50 years old), the cream prepared in Formulation Example 2 was applied to the right side of the face, and the cream prepared in Comparative Formulation Example 2 was applied to the left side of the face. The application of the cream was performed twice a day for 6 weeks. On other women subjects (30-50 years old), the cream prepared in Formulation Example 3 was applied to the right side of the face, and the cream prepared in Comparative Formulation Example 1 was applied to the left side of the face. The application of the cream was performed twice a day for 6 weeks.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011551981A JP5856847B2 (en) | 2009-02-27 | 2010-02-25 | Skin external preparation composition containing Matsune extract |
US13/203,127 US20120021081A1 (en) | 2009-02-27 | 2010-02-25 | Composition for skin external application containing red pine root extract |
CN201080008113.6A CN102316849B (en) | 2009-02-27 | 2010-02-25 | Composition for skin external application containing red pine root extract |
US13/756,227 US8828456B2 (en) | 2009-02-27 | 2013-01-31 | Method of external skin application of composition containing red pine root extract |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20090017074 | 2009-02-27 | ||
KR10-2009-0017074 | 2009-02-27 | ||
KR1020090033750A KR101601024B1 (en) | 2009-02-27 | 2009-04-17 | Composition for skin external application containing the extract of red pine roots |
KR10-2009-0033750 | 2009-04-17 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/203,127 A-371-Of-International US20120021081A1 (en) | 2009-02-27 | 2010-02-25 | Composition for skin external application containing red pine root extract |
US13/756,227 Division US8828456B2 (en) | 2009-02-27 | 2013-01-31 | Method of external skin application of composition containing red pine root extract |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010098595A2 true WO2010098595A2 (en) | 2010-09-02 |
WO2010098595A3 WO2010098595A3 (en) | 2011-01-06 |
Family
ID=42666057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2010/001180 WO2010098595A2 (en) | 2009-02-27 | 2010-02-25 | Composition for skin external applicationcontaining red pine root extract |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2010098595A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012052685A1 (en) * | 2010-10-19 | 2012-04-26 | Brigitte Gourlaouen | Product for treating cellulite, skin ageing and for preventing inflammatory processes |
JP2013035807A (en) * | 2011-08-10 | 2013-02-21 | Rohto Pharmaceutical Co Ltd | Elastic-fiber formation promotor |
JP2013035808A (en) * | 2011-08-10 | 2013-02-21 | Rohto Pharmaceutical Co Ltd | Ltbp-4 production promotor |
WO2012156419A3 (en) * | 2011-05-17 | 2013-03-28 | Chanel Parfums Beaute | Lmna, fnta and face-1 activators for preventing and/or attenuating skin ageing and/or hydrating skin |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003277223A (en) * | 2002-03-19 | 2003-10-02 | Dhc Co | Matrix metalloprotease inhibitor and skin elasticity- retaining cosmetic |
KR20070119296A (en) * | 2006-06-15 | 2007-12-20 | 황보식 | Agent having effects of skin aging resister and skin whitening, manufactured using extract of pine tree as its main ingredient |
-
2010
- 2010-02-25 WO PCT/KR2010/001180 patent/WO2010098595A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003277223A (en) * | 2002-03-19 | 2003-10-02 | Dhc Co | Matrix metalloprotease inhibitor and skin elasticity- retaining cosmetic |
KR20070119296A (en) * | 2006-06-15 | 2007-12-20 | 황보식 | Agent having effects of skin aging resister and skin whitening, manufactured using extract of pine tree as its main ingredient |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012052685A1 (en) * | 2010-10-19 | 2012-04-26 | Brigitte Gourlaouen | Product for treating cellulite, skin ageing and for preventing inflammatory processes |
WO2012156419A3 (en) * | 2011-05-17 | 2013-03-28 | Chanel Parfums Beaute | Lmna, fnta and face-1 activators for preventing and/or attenuating skin ageing and/or hydrating skin |
JP2013035807A (en) * | 2011-08-10 | 2013-02-21 | Rohto Pharmaceutical Co Ltd | Elastic-fiber formation promotor |
JP2013035808A (en) * | 2011-08-10 | 2013-02-21 | Rohto Pharmaceutical Co Ltd | Ltbp-4 production promotor |
Also Published As
Publication number | Publication date |
---|---|
WO2010098595A3 (en) | 2011-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9132294B2 (en) | Compositions and methods for stimulation MAGP-1 to improve the appearance of skin | |
KR101932766B1 (en) | Dendrobium chrysotoxum extract and its cosmetic use as an anti-aging agent | |
US8828456B2 (en) | Method of external skin application of composition containing red pine root extract | |
JP7411327B2 (en) | Compositions containing natural extracts and their use for skin and hair | |
US20140255523A1 (en) | Use of Tiliacora Triandra in Cosmetics and Compositions Thereof | |
KR101543461B1 (en) | Cosmetic composition for improving skin photoaging comprising Lespedeza cuneata LPC extract | |
KR101194891B1 (en) | Pharmaceutical composition containing extract of Syngnathoides biaculeatus for preventing and curing of UV-induced skin damage | |
KR20160063394A (en) | Cosmetic or dermatological use of an extract of hamamelis virginiana | |
JP2004519208A (en) | Yeast extract treated with peroxide and method for producing the same | |
KR102161599B1 (en) | Cosmetic compositions comprising marine plants | |
KR101627051B1 (en) | Natural liposome comprising vitamin C, process for the preparation thereof, and cosmetic composition comprising the same | |
WO2010098595A2 (en) | Composition for skin external applicationcontaining red pine root extract | |
RU2532343C2 (en) | Skin regeneration composition and method | |
WO2012002950A1 (en) | Use of tiliacora triandra in cosmetics and compositions thereof | |
KR102063686B1 (en) | Skin external composition containing extract of soybean root | |
KR20100021755A (en) | Cosmetic composition for anti-aging of the skin | |
KR101841118B1 (en) | Composition for skin external application comprising extract of scenedesmus sp. | |
KR20070082635A (en) | Antiaging composition for external skin application containing the needles of red pine | |
KR102094667B1 (en) | Composition for anti-aging comprising Rhodobacter sphaeroides strain or culture solution of the strain | |
KR102135551B1 (en) | A cosmetic composition comprising red propolis extract having formononetin as a maker compound with excellent anti aging effect | |
EP4037657B1 (en) | A punica granatum extract and its cosmetic uses | |
KR20110041102A (en) | Skin external composition for antiaging containing extract of plant stem cells isolated from root apical meristem (ram) of pinus densiflora | |
JP2002284648A (en) | Composition for hair restorer | |
US20240091294A1 (en) | Extract of Top Growth of Holy Basil, and Cosmetic or Dermatological Compositions Containing Same | |
JP7197228B2 (en) | multipurpose serum |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201080008113.6 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10746434 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011551981 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13203127 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10746434 Country of ref document: EP Kind code of ref document: A2 |